Bg-c9074

Other Medications

1 Clinical Trials

Description

BG-C9074 is an experimental medication currently being studied in clinical trials for advanced solid tumors, including colorectal cancer. It is being evaluated in Phase 1 trials to determine its safety, how the body processes it (pharmacokinetics), its effects on the body (pharmacodynamics), and if it shows early signs of fighting the cancer (preliminary antitumor activity). These early-phase trials are designed to find the right dose and understand how patients react to the drug. The trials may also explore BG-C9074 in combination with other cancer therapies, such as bevacizumab or tislelizumab. Some trials specifically include patients whose tumors have a HER2 mutation.

Mechanism of Action

BG-C9074 is a novel investigational agent. The specific way it works (its mechanism of action) is still being studied in clinical trials. Researchers are working to understand how it interacts with cancer cells or the tumor environment to potentially slow or stop cancer growth.

Side Effects

As BG-C9074 is an experimental drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. The primary focus of Phase 1 trials is to assess safety and determine the maximum tolerated dose. Specific side effects observed in the ongoing trials are not yet fully characterized or publicly available. Patients participating in these trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06233942 Phase 1
Recruiting
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
United States, Australia, Brazil, China, Japan

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.